Skip to main content
. 2022 Aug 15;12(8):3512–3531.

Table 1.

Studies on predicting pCR by VAB after NAC

Study Type Inclusion n Means of prediction FNR and NPV
Heil 2015 [44] prospective cCR after NAC 164 116 CCs; mammographically guided VABs: NPV 100%, FNR 0%;
46 VABs ultrasound-guided VABs: NPV 53.3%
CCs: NPV 70.2%; FNR 60.9%
The existence of a clip marker tended to improve the NPV (odds ratio 1.98)
Heil 2016 [45] prospective clinical/imaging partial or complete response, lesion visible in ultrasound 50 Ultrasound-guided VAB NPV: 76.7% FNR: 25.9%
Given a histopathologically representative VAB sample (n =38), the NPV was 94.4%, and the FNR was 4.8%
Heil 2020 [46] prospective T1-3 398 Image-guided VAB FNR 17.8%
If no residual lesions were found in imaging and VAB, the FNR could be reduced to 6.2%, or the FNR could be reduced to 0% by performing VAB with the giant needle by volume (7-gauge)
Kuerer et al. [47] prospective T1-3, N0-3 TNBC or HER2-positive 40 ultrasound-guided or mammography-guided FNA and VAB VAB alone was more accurate than FNA alone
Combined FNA/VAB demonstrated an accuracy of 98%, FNR was 5%, and NPV was 95%
If the admission criteria are stringent, FNR could be further reduced to 3.2%
MICRA study [48] prospective N0, radiologic partial or complete response on MRI 525 Ultrasound-guided 14 G biopsies targeted around pre-NAC-placed marker (four central; four peripheral) The FNR was 37%. Sensitivity was 63%, specificity was 100%, PPV was 100%, and NPV was 75%
NOSTRA PRELIM study [51] prospective ER-negative or HER2-positive; lesion size >1 cm; cN+ 150 Ultrasound-directed biopsy FNR < 10%
Sutton [52] prospective IA to IIIC; cCR on MRI 20 MRI-guided biopsy NPV was 92.8%, accuracy was 95%, sensitivity was 85.8%, PPV was 100%, and specificity was 100%
Tasoulis MK [50] pooled analysis - 166 Image-guided biopsy The FNR was 3.2%, NPV was 97.4%, overall accuracy was 89.5%
Lee [53] prospective cCR on MRI 20 Ultrasound-guided biopsy NPV, accuracy, and FNR was 87.1%, 90.0%, and 30.8%

Abbreviations: NAC, neoadjuvant chemotherapy; pCR, complete pathological response; cCR, clinical complete response; CCs, Core-cut-MIB; VAB, Vacuum-assisted-MIB; TAD: targeted axillary dissection; FNR, false-negative rate, PPV, positive predictive values; NPV, negative predictive values; MRI, magnetic resonance imaging.